The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pulmonary Drug Delivery Devices-Global Market Insights and Sales Trends 2024
Synopsis
The global Pulmonary Drug Delivery Devices market size is expected to reach US$ 3899 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Drug Delivery Devices in various end use industries. The expanding demands from the Asthma, COPD, Cystic Fibrosis and Other, are propelling Pulmonary Drug Delivery Devices market. Dry Powder Inhaler, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Metered Dose Inhaler segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pulmonary Drug Delivery Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pulmonary Drug Delivery Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pulmonary Drug Delivery Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pulmonary Drug Delivery Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pulmonary Drug Delivery Devices covered in this report include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb and Mylan N.V, etc.
The global Pulmonary Drug Delivery Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Global Pulmonary Drug Delivery Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pulmonary Drug Delivery Devices market, Segment by Type:
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Global Pulmonary Drug Delivery Devices market, by Application
Asthma
COPD
Cystic Fibrosis
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Pulmonary Drug Delivery Devices market size is expected to reach US$ 3899 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Drug Delivery Devices in various end use industries. The expanding demands from the Asthma, COPD, Cystic Fibrosis and Other, are propelling Pulmonary Drug Delivery Devices market. Dry Powder Inhaler, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Metered Dose Inhaler segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pulmonary Drug Delivery Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pulmonary Drug Delivery Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pulmonary Drug Delivery Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pulmonary Drug Delivery Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pulmonary Drug Delivery Devices covered in this report include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb and Mylan N.V, etc.
The global Pulmonary Drug Delivery Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Global Pulmonary Drug Delivery Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pulmonary Drug Delivery Devices market, Segment by Type:
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Global Pulmonary Drug Delivery Devices market, by Application
Asthma
COPD
Cystic Fibrosis
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pulmonary Drug Delivery Devices Market Overview
1.1 Pulmonary Drug Delivery Devices Product Overview
1.2 Pulmonary Drug Delivery Devices Market Segment by Type
1.2.1 Dry Powder Inhaler
1.2.2 Metered Dose Inhaler
1.2.3 Nebulizer
1.3 Global Pulmonary Drug Delivery Devices Market Size by Type
1.3.1 Global Pulmonary Drug Delivery Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Pulmonary Drug Delivery Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pulmonary Drug Delivery Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pulmonary Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pulmonary Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pulmonary Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pulmonary Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pulmonary Drug Delivery Devices Sales Breakdown by Type (2018-2023)
2 Global Pulmonary Drug Delivery Devices Market Competition by Company
2.1 Global Top Players by Pulmonary Drug Delivery Devices Sales (2018-2023)
2.2 Global Top Players by Pulmonary Drug Delivery Devices Revenue (2018-2023)
2.3 Global Top Players by Pulmonary Drug Delivery Devices Price (2018-2023)
2.4 Global Top Manufacturers Pulmonary Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pulmonary Drug Delivery Devices Market Competitive Situation and Trends
2.5.1 Pulmonary Drug Delivery Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pulmonary Drug Delivery Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Pulmonary Drug Delivery Devices Market
2.8 Key Manufacturers Pulmonary Drug Delivery Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pulmonary Drug Delivery Devices Status and Outlook by Region
3.1 Global Pulmonary Drug Delivery Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pulmonary Drug Delivery Devices Historic Market Size by Region
3.2.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Pulmonary Drug Delivery Devices Sales in Value by Region (2018-2023)
3.2.3 Global Pulmonary Drug Delivery Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pulmonary Drug Delivery Devices Forecasted Market Size by Region
3.3.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Pulmonary Drug Delivery Devices Sales in Value by Region (2024-2029)
3.3.3 Global Pulmonary Drug Delivery Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pulmonary Drug Delivery Devices by Application
4.1 Pulmonary Drug Delivery Devices Market Segment by Application
4.1.1 Asthma
4.1.2 COPD
4.1.3 Cystic Fibrosis
4.1.4 Other
4.2 Global Pulmonary Drug Delivery Devices Market Size by Application
4.2.1 Global Pulmonary Drug Delivery Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Pulmonary Drug Delivery Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pulmonary Drug Delivery Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pulmonary Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pulmonary Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pulmonary Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pulmonary Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pulmonary Drug Delivery Devices Sales Breakdown by Application (2018-2023)
5 North America Pulmonary Drug Delivery Devices by Country
5.1 North America Pulmonary Drug Delivery Devices Historic Market Size by Country
5.1.1 North America Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pulmonary Drug Delivery Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Pulmonary Drug Delivery Devices Sales in Value by Country (2018-2023)
5.2 North America Pulmonary Drug Delivery Devices Forecasted Market Size by Country
5.2.1 North America Pulmonary Drug Delivery Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Pulmonary Drug Delivery Devices Sales in Value by Country (2024-2029)
6 Europe Pulmonary Drug Delivery Devices by Country
6.1 Europe Pulmonary Drug Delivery Devices Historic Market Size by Country
6.1.1 Europe Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pulmonary Drug Delivery Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Pulmonary Drug Delivery Devices Sales in Value by Country (2018-2023)
6.2 Europe Pulmonary Drug Delivery Devices Forecasted Market Size by Country
6.2.1 Europe Pulmonary Drug Delivery Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Pulmonary Drug Delivery Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Pulmonary Drug Delivery Devices by Region
7.1 Asia-Pacific Pulmonary Drug Delivery Devices Historic Market Size by Region
7.1.1 Asia-Pacific Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pulmonary Drug Delivery Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pulmonary Drug Delivery Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pulmonary Drug Delivery Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pulmonary Drug Delivery Devices Sales in Value by Region (2024-2029)
8 Latin America Pulmonary Drug Delivery Devices by Country
8.1 Latin America Pulmonary Drug Delivery Devices Historic Market Size by Country
8.1.1 Latin America Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pulmonary Drug Delivery Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pulmonary Drug Delivery Devices Sales in Value by Country (2018-2023)
8.2 Latin America Pulmonary Drug Delivery Devices Forecasted Market Size by Country
8.2.1 Latin America Pulmonary Drug Delivery Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pulmonary Drug Delivery Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Pulmonary Drug Delivery Devices by Country
9.1 Middle East and Africa Pulmonary Drug Delivery Devices Historic Market Size by Country
9.1.1 Middle East and Africa Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pulmonary Drug Delivery Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pulmonary Drug Delivery Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pulmonary Drug Delivery Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Pulmonary Drug Delivery Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pulmonary Drug Delivery Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boehringer Ingelheim GmbH
10.1.1 Boehringer Ingelheim GmbH Company Information
10.1.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Products Offered
10.1.5 Boehringer Ingelheim GmbH Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis AG Pulmonary Drug Delivery Devices Products Offered
10.2.5 Novartis AG Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca Pulmonary Drug Delivery Devices Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Teva Pharmaceutical Industries
10.5.1 Teva Pharmaceutical Industries Company Information
10.5.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Products Offered
10.5.5 Teva Pharmaceutical Industries Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Merck Pulmonary Drug Delivery Devices Products Offered
10.6.5 Merck Recent Development
10.7 MannKind
10.7.1 MannKind Company Information
10.7.2 MannKind Introduction and Business Overview
10.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 MannKind Pulmonary Drug Delivery Devices Products Offered
10.7.5 MannKind Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Mylan N.V
10.9.1 Mylan N.V Company Information
10.9.2 Mylan N.V Introduction and Business Overview
10.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan N.V Pulmonary Drug Delivery Devices Products Offered
10.9.5 Mylan N.V Recent Development
10.10 Omron Corp
10.10.1 Omron Corp Company Information
10.10.2 Omron Corp Introduction and Business Overview
10.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Omron Corp Pulmonary Drug Delivery Devices Products Offered
10.10.5 Omron Corp Recent Development
10.11 F. Hoffmann-La Roche
10.11.1 F. Hoffmann-La Roche Company Information
10.11.2 F. Hoffmann-La Roche Introduction and Business Overview
10.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Products Offered
10.11.5 F. Hoffmann-La Roche Recent Development
10.12 3M Healthcare
10.12.1 3M Healthcare Company Information
10.12.2 3M Healthcare Introduction and Business Overview
10.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 3M Healthcare Pulmonary Drug Delivery Devices Products Offered
10.12.5 3M Healthcare Recent Development
10.13 Sunovion Pharmaceuticals
10.13.1 Sunovion Pharmaceuticals Company Information
10.13.2 Sunovion Pharmaceuticals Introduction and Business Overview
10.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Products Offered
10.13.5 Sunovion Pharmaceuticals Recent Development
10.14 Koninklijke Philips N.V
10.14.1 Koninklijke Philips N.V Company Information
10.14.2 Koninklijke Philips N.V Introduction and Business Overview
10.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Products Offered
10.14.5 Koninklijke Philips N.V Recent Development
10.15 Gerresheimer AG
10.15.1 Gerresheimer AG Company Information
10.15.2 Gerresheimer AG Introduction and Business Overview
10.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Products Offered
10.15.5 Gerresheimer AG Recent Development
10.16 Bespak
10.16.1 Bespak Company Information
10.16.2 Bespak Introduction and Business Overview
10.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Bespak Pulmonary Drug Delivery Devices Products Offered
10.16.5 Bespak Recent Development
10.17 AptarGroup
10.17.1 AptarGroup Company Information
10.17.2 AptarGroup Introduction and Business Overview
10.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.17.4 AptarGroup Pulmonary Drug Delivery Devices Products Offered
10.17.5 AptarGroup Recent Development
10.18 SHL Group
10.18.1 SHL Group Company Information
10.18.2 SHL Group Introduction and Business Overview
10.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.18.4 SHL Group Pulmonary Drug Delivery Devices Products Offered
10.18.5 SHL Group Recent Development
10.19 Nypro Healthcare
10.19.1 Nypro Healthcare Company Information
10.19.2 Nypro Healthcare Introduction and Business Overview
10.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Products Offered
10.19.5 Nypro Healthcare Recent Development
10.20 Hovione
10.20.1 Hovione Company Information
10.20.2 Hovione Introduction and Business Overview
10.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Hovione Pulmonary Drug Delivery Devices Products Offered
10.20.5 Hovione Recent Development
10.21 Chiesi Farmaceutici S.P.A
10.21.1 Chiesi Farmaceutici S.P.A Company Information
10.21.2 Chiesi Farmaceutici S.P.A Introduction and Business Overview
10.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Products Offered
10.21.5 Chiesi Farmaceutici S.P.A Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pulmonary Drug Delivery Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pulmonary Drug Delivery Devices Industrial Chain Analysis
11.4 Pulmonary Drug Delivery Devices Market Dynamics
11.4.1 Pulmonary Drug Delivery Devices Industry Trends
11.4.2 Pulmonary Drug Delivery Devices Market Drivers
11.4.3 Pulmonary Drug Delivery Devices Market Challenges
11.4.4 Pulmonary Drug Delivery Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pulmonary Drug Delivery Devices Distributors
12.3 Pulmonary Drug Delivery Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
